Related Content
April 15, 2024 — The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II ...
April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with ...
April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its ...
March 12, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling its HeartMate Touch ...
January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed ...
November 20, 2023 — Abbott announced new late-breaking data that show advanced heart failure patients living with its ...
November 7, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...
October 30, 2023 — Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK ...
October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive ...
The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...